首页> Journal of clinical psychopharmacology> Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

导出原文传递

翻译打印收藏纠错

作者： Kinon BJ ^[1] ; Liu-Seifert H ; Adams DH ; Citrome L

作者单位： Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Kinon_Bruce@lilly.com ^[1]

关键词 olanzapine therapeutic aspects Financially poor symptoms <1>

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical psychopharmacology

2006年26卷6期

632-637页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of clinical psychopharmacology

2006年26卷6期

632-637页

检索历史清除

Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

Journal of clinical psychopharmacology

相似文献

Journal of clinical psychopharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

Journal of clinical psychopharmacology

相似文献

Journal of clinical psychopharmacology

相关期刊

检索历史清除